The patented invention provides methods for the development of new therapeutic agents for adiposity as well as early indicators for the prevention thereof through a most suitable polygenic mouse line with comparable characteristics to the disease in humans.
Further Information: PDF
PVA Mecklenburg-Vorpommern AG
Phone: +49 (0)381/49 74 74 0
Contact
Antonio Martinez
